3-Methylbutanamide
-
3-Methylbutanamide
structure -
-
CAS No:
541-46-8
-
Formula:
C5H11NO
-
Chemical Name:
3-Methylbutanamide
-
Synonyms:
Butanamide,3-methyl-;Isovaleramide;3-Methylbutanamide;Isovaleric acid amide;3-Methylbutyramide;β-Methylbutyramide;Isopentanamide;NSC 402555;NPS 1776;502641-01-2
- Categories:
-
CAS No:
Description
Isovaleramide is an active principle on central nervous system from Valeriana pavonii, as an anticonvulsant.Target:in vitro: Isovaleramide (300 μM) exhibits a 42% of inhibition of the binding of 3H-FNZ to its sites.in vivo: Isovaleramide at 100 mg/Kg, p.o, evidences a 90% index protection against the maximal electroshock seizure in mice (MES).
3-Methylbutanamide Basic Attributes
101.15
101.15
1740789
208-781-1
9CP4KB634M
760408|402555
DTXSID3060249
2924199090
Safety Information
22-24/25
EJ3650000
Xi
P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, P501
H315
|Warning|H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]|P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
3-Methylbutanamide Use and Manufacturing
RT transferase inhibitor, antiviral
Butanamide, 3-methyl-: ACTIVE
Computed Properties
Molecular Weight:101.15
XLogP3:0.4
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:1
Rotatable Bond Count:2
Exact Mass:101.084063974
Monoisotopic Mass:101.084063974
Topological Polar Surface Area:43.1
Heavy Atom Count:7
Complexity:68.5
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of 3-Methylbutanamide
-
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives
Latest News on 3-Methylbutanamide
- BMS Over $900 Million to Help Develop Potential 'Best-in-class' SHP2 Inhibitors
- AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan
- Designing peptide inhibitors for possible COVID-19 treatments
- Chinese scientists discover the inhibitors of SARS-CoV-2
Learn More Other Chemicals
-
Dabrafenib
1195765-45-7
-
BOC-VAL-VAL-OH
69209-73-0
-
BMS 303141
943962-47-8
-
(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanamide Formula
60117-17-1
-
(2S)-2-acetamido-6-amino-N-[(2S)-2-amino-3-methylbutanoyl]-N-propylhexanamide Formula
57899-96-4
-
1-(6-methoxy-1,3-benzothiazol-2-yl)-3-phenylurea Formula
26130-02-9
-
L-Tyrosyl-L-phenylalanine Structure
17355-11-2
-
C-REACTIVE PROTEIN FRAGMENT 77-82 Structure
130349-01-8
-
What is Sildenafil
139755-83-2
-
What is Dacomitinib
1110813-31-4